Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
+3.05%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$34.8B
AUM Growth
+$34.8B
(-6%)
Cap. Flow
-$3.02B
Cap. Flow
% of AUM
-8.66%
Top 10 Holdings %
Top 10 Hldgs %
57.31%
Holding
83
New
5
Increased
11
Reduced
23
Closed
–
Top Buys
| 1 |
ASML
ASML
|
$665M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$568M |
| 3 |
TransDigm Group
TDG
|
$400M |
| 4 |
Adobe
ADBE
|
$310M |
| 5 |
Eli Lilly
LLY
|
$226M |
Top Sells
| 1 |
Uber
UBER
|
$1.66B |
| 2 |
ServiceNow
NOW
|
$1.39B |
| 3 |
Netflix
NFLX
|
$732M |
| 4 |
Blackstone
BX
|
$281M |
| 5 |
Visa
V
|
$182M |
Sector Composition
| 1 | Technology | 35.65% |
| 2 | Financials | 19.62% |
| 3 | Healthcare | 17.3% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Communication Services | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bank of New York Mellon
BK
$73.8B
| $2.28M | 0.01% |
29,704
| – | – |
|
52
Pfizer
PFE
$142B
| $2.25M | 0.01% |
84,911
| – | – |
|
53
Illumina
ILMN
$15.5B
| $2.1M | 0.01% |
15,721
-400
| -2% | -$53.5K |
|
54
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.05M | 0.01% |
4,532
| – | – |
|
|
55
Berkshire Hathaway Class A
BRK.A
$1.08T
| $2.04M | 0.01% |
3
| – | – |
|
56
Estee Lauder
EL
$32.7B
| $1.91M | 0.01% |
25,450
-300
| -1% | -$22.5K |
|
57
NextEra Energy, Inc.
NEE
$150B
| $1.89M | 0.01% |
26,400
| – | – |
|
58
Dell
DELL
$81.8B
| $1.73M | 0.01% |
+15,000
| New | +$1.73M |
|
59
Advanced Micro Devices
AMD
$263B
| $1.69M | ﹤0.01% |
13,972
| – | – |
|
60
Cisco
CSCO
$268B
| $1.68M | ﹤0.01% |
28,441
| – | – |
|
61
Veralto
VLTO
$26.1B
| $1.5M | ﹤0.01% |
14,700
+200
| +1% | +$20.4K |
|
|
ETG
62
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.58B
| $1.49M | ﹤0.01% |
82,000
| – | – |
|
63
Coca-Cola
KO
$297B
| $1.35M | ﹤0.01% |
21,671
| – | – |
|
64
Exxon Mobil
XOM
$489B
| $989K | ﹤0.01% |
9,191
-12
| -0.1% | -$1.29K |
|
65
BioMarin Pharmaceuticals
BMRN
$11.3B
| $986K | ﹤0.01% |
15,000
| – | – |
|
66
Agios Pharmaceuticals
AGIO
$2.28B
| $986K | ﹤0.01% |
30,000
| – | – |
|
67
Merck
MRK
$214B
| $768K | ﹤0.01% |
7,718
| – | – |
|
68
Duke Energy
DUK
$94.8B
| $679K | ﹤0.01% |
6,302
| – | – |
|
69
Freeport-McMoran
FCX
$64.5B
| $545K | ﹤0.01% |
14,319
| – | – |
|
70
Zoetis
ZTS
$67.8B
| $425K | ﹤0.01% |
2,611
| – | – |
|
71
Tesla
TSLA
$1.06T
| $399K | ﹤0.01% |
989
| – | – |
|
72
Arrowhead Research
ARWR
$3.55B
| $376K | ﹤0.01% |
20,000
| – | – |
|
73
Procter & Gamble
PG
$370B
| $369K | ﹤0.01% |
2,200
| – | – |
|
74
Prothena Corp
PRTA
$445M
| $333K | ﹤0.01% |
24,060
| – | – |
|
75
Home Depot
HD
$404B
| $302K | ﹤0.01% |
777
| – | – |
|